Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet

DRUG2 trials

Sponsors

Galenicum Health

Conditions

BioequivalenceDiabetes Mellitus, Type 2

Phase 1

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

CompletedNCT06124560

Galenicum HealthBioequivalence, Diabetes Mellitus, Type 2

Start: 2022-10-28End: 2022-11-07Updated: 2023-11-09

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

CompletedNCT06124573

Galenicum HealthBioequivalence, Diabetes Mellitus, Type 2

Start: 2022-11-07End: 2022-11-21Updated: 2023-11-09